PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RYTM vs. VGT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between RYTM and VGT is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

RYTM vs. VGT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rhythm Pharmaceuticals, Inc. (RYTM) and Vanguard Information Technology ETF (VGT). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
0.09%
1.17%
RYTM
VGT

Key characteristics

Sharpe Ratio

RYTM:

0.59

VGT:

1.29

Sortino Ratio

RYTM:

1.16

VGT:

1.75

Omega Ratio

RYTM:

1.14

VGT:

1.23

Calmar Ratio

RYTM:

0.92

VGT:

1.82

Martin Ratio

RYTM:

1.82

VGT:

6.46

Ulcer Index

RYTM:

16.46%

VGT:

4.29%

Daily Std Dev

RYTM:

50.65%

VGT:

21.60%

Max Drawdown

RYTM:

-92.10%

VGT:

-54.63%

Current Drawdown

RYTM:

-19.89%

VGT:

-5.77%

Returns By Period

In the year-to-date period, RYTM achieves a -3.64% return, which is significantly lower than VGT's -1.92% return.


RYTM

YTD

-3.64%

1M

-2.35%

6M

0.09%

1Y

32.60%

5Y*

21.38%

10Y*

N/A

VGT

YTD

-1.92%

1M

-4.66%

6M

1.17%

1Y

27.43%

5Y*

19.81%

10Y*

20.94%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RYTM vs. VGT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RYTM
The Risk-Adjusted Performance Rank of RYTM is 7070
Overall Rank
The Sharpe Ratio Rank of RYTM is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of RYTM is 6767
Sortino Ratio Rank
The Omega Ratio Rank of RYTM is 6464
Omega Ratio Rank
The Calmar Ratio Rank of RYTM is 8080
Calmar Ratio Rank
The Martin Ratio Rank of RYTM is 6868
Martin Ratio Rank

VGT
The Risk-Adjusted Performance Rank of VGT is 6262
Overall Rank
The Sharpe Ratio Rank of VGT is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of VGT is 5858
Sortino Ratio Rank
The Omega Ratio Rank of VGT is 6161
Omega Ratio Rank
The Calmar Ratio Rank of VGT is 6666
Calmar Ratio Rank
The Martin Ratio Rank of VGT is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RYTM vs. VGT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Rhythm Pharmaceuticals, Inc. (RYTM) and Vanguard Information Technology ETF (VGT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RYTM, currently valued at 0.59, compared to the broader market-2.000.002.000.591.29
The chart of Sortino ratio for RYTM, currently valued at 1.16, compared to the broader market-4.00-2.000.002.004.001.161.75
The chart of Omega ratio for RYTM, currently valued at 1.14, compared to the broader market0.501.001.502.001.141.23
The chart of Calmar ratio for RYTM, currently valued at 0.92, compared to the broader market0.002.004.006.000.921.82
The chart of Martin ratio for RYTM, currently valued at 1.82, compared to the broader market0.0010.0020.001.826.46
RYTM
VGT

The current RYTM Sharpe Ratio is 0.59, which is lower than the VGT Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of RYTM and VGT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
0.59
1.29
RYTM
VGT

Dividends

RYTM vs. VGT - Dividend Comparison

RYTM has not paid dividends to shareholders, while VGT's dividend yield for the trailing twelve months is around 0.61%.


TTM20242023202220212020201920182017201620152014
RYTM
Rhythm Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VGT
Vanguard Information Technology ETF
0.61%0.60%0.65%0.91%0.64%0.82%1.11%1.29%0.99%1.31%1.28%1.12%

Drawdowns

RYTM vs. VGT - Drawdown Comparison

The maximum RYTM drawdown since its inception was -92.10%, which is greater than VGT's maximum drawdown of -54.63%. Use the drawdown chart below to compare losses from any high point for RYTM and VGT. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-19.89%
-5.77%
RYTM
VGT

Volatility

RYTM vs. VGT - Volatility Comparison

Rhythm Pharmaceuticals, Inc. (RYTM) has a higher volatility of 12.51% compared to Vanguard Information Technology ETF (VGT) at 6.33%. This indicates that RYTM's price experiences larger fluctuations and is considered to be riskier than VGT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
12.51%
6.33%
RYTM
VGT
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab